Organ Preservation Solutions Market Expanding at a CAGR of 7.2% Through 2035
FactMR today released its latest report on the Organ
Preservation Solutions Market, providing comprehensive insights into the
global market’s significant growth driven by the rising demand for organ
transplants, increasing prevalence of organ failure, and advancements in
preservation technologies. Valued at USD 286.8 million in 2025, the market is
projected to grow at a compound annual growth rate (CAGR) of 7.2%, reaching USD
574.7 million by 2035. This expansion highlights the critical role of organ
preservation solutions in bridging the gap between organ availability and
successful transplantation outcomes.
Download Free Sample
Copy of Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=7752
Market Outlook and Growth Projections
The global organ preservation solutions market is poised for
substantial growth from 2025 to 2035, driven by the increasing number of organ
transplant procedures and the rising burden of chronic diseases leading to
organ failure. Organ preservation solutions, such as University of Wisconsin
(UW), Custodiol HTK, and Perfadex, are essential for maintaining organ
viability during storage and transportation. The report projects the market to
grow from USD 286.8 million in 2025 to USD 574.7 million by 2035, with a
consistent CAGR of 7.2%. This growth is fueled by technological advancements in
preservation techniques, growing organ donation networks, and increasing
healthcare investments, creating significant opportunities for stakeholders.
Key Drivers Fueling Market Demand
The organ preservation solutions market is propelled by
several key factors. The rising prevalence of chronic diseases, such as kidney
failure, liver cirrhosis, and heart disease, is driving demand for organ transplants,
with over 120,000 patients on U.S. transplant waiting lists in 2022. The
increasing geriatric population, projected to reach 2 billion by 2050, further
escalates the need for transplants due to age-related organ failures.
Technological advancements, such as normothermic machine perfusion (NMP), which
maintains organs in near-physiological conditions, are enhancing transplant
success rates and expanding the donor pool. Government initiatives, like
India’s National Organ Transplant Programme, and awareness campaigns are
boosting organ donation rates, particularly in Asia-Pacific, where China’s
market is expected to grow at a CAGR of 9%. Additionally, innovations like
bioengineered solutions and oxygenated perfusion are improving organ viability,
further driving market growth.
Challenges and Restraints in the Sector
Despite its promising outlook, the market faces significant
challenges. A critical shortage of organ donors, with only 49 deceased donors
per million population in Spain in 2019, limits transplant availability. High
costs of transplant procedures and preservation technologies, often ranging
from USD 100,000 to over USD 1 million, restrict access, particularly in
developing regions. Ethical concerns, such as informed consent and potential exploitation
in organ procurement, as highlighted in recent posts on X, pose additional
barriers. The report also notes logistical challenges, including procurement
delays and limited cryogenic infrastructure in regions like Asia-Pacific and
the Middle East, which contribute to organ wastage. Providers must address
these issues through cost-effective solutions, regulatory harmonization, and
enhanced infrastructure to ensure broader accessibility.
Segment-Wise Insights and Dominant Trends
The report provides detailed segmentation analysis,
identifying static cold storage (SCS) as the dominant technique, holding a 45%
market share in 2024 due to its simplicity, cost-effectiveness, and wide
applicability for organs like kidneys and livers. Normothermic machine
perfusion (NMP) is the fastest-growing segment, with a projected CAGR of 7.2%,
driven by its ability to reduce ischemia-reperfusion injury and assess organ
viability. By organ type, kidneys lead with a 35% share, followed by livers and
lungs, with lung preservation growing rapidly due to Perfadex’s effectiveness.
Hospitals and organ transplant centers dominate end-user segments, while organ
banks are gaining traction. Key trends include the adoption of AI for organ
quality assessment, portable oxygenated perfusion devices, and personalized
preservation solutions tailored to specific organs, enhancing transplant
outcomes.
Regional Outlook and Growth Hotspots
North America holds the largest market share, with a 46%
share in 2024, driven by advanced healthcare infrastructure, high transplant
volumes (42,887 in the U.S. in 2022), and FDA approvals for innovative systems
like TransMedics’ OCS Heart System. Europe follows, with Spain leading due to
its robust organ donation program. The Asia-Pacific region is expected to
exhibit the fastest growth, with a projected CAGR of 9%, fueled by rising
healthcare investments, an aging population, and increasing organ donation
awareness in China and India. Latin America and the Middle East and Africa (MEA)
are emerging markets, with Brazil performing over 12,000 transplants in 2021
and initiatives like Mexico’s ALIANZA boosting donation rates. The report
identifies Asia-Pacific as a key growth engine due to its expanding transplant
infrastructure and supportive regulations.
Recent Developments
The market has seen significant advancements in 2024 and
early 2025. In November 2023, Paragonix Technologies launched a comprehensive
donor organ procurement and preservation network across the U.S., enhancing
logistics and transplant coordination. In April 2022, TransMedics received FDA
approval for its OCS Heart System, enabling ex vivo preservation of donor
hearts. Recent posts on X highlight ethical concerns and innovations, such as
stem cell-based organ repair, indicating a shift toward alternative solutions.
Companies like XVIVO Perfusion collaborated with Contatti Medical in 2021 to
expand transplant services in Brazil. The adoption of fuel cell technology for
sustainable power in preservation systems is also gaining traction, supporting
market growth.
Key Players Insights
Leading players are driving innovation through strategic
partnerships and product advancements. Waters Medical Systems leads with its
kidney preservation solutions, while XVIVO Perfusion excels in lung
preservation with Perfadex. TransMedics dominates with its Organ Care System,
and OrganOx focuses on liver preservation. Other key players, including
Paragonix Technologies, Dr. Franz Koehler Chemie GmbH, Accord Healthcare, 21ST
Century Medicine, Shanghai Genext Pharmaceutical Technology, and Bridge to
Life, are investing in NMP and bioengineered solutions. Recent developments
include Paragonix’s milestone of preserving over 2,000 donor organs in August
2022. These companies are pursuing R&D, acquisitions, and regional
expansion to meet growing transplant demands, with strong growth projected
through 2035.
Competitive Landscape
The market features a moderately fragmented competitive
ecosystem with key players driving innovation and market share. Companies
profiled include Waters Medical Systems, XVIVO Perfusion, TransMedics, OrganOx,
Paragonix Technologies, Dr. Franz Koehler Chemie GmbH, Accord Healthcare, 21ST
Century Medicine, Shanghai Genext Pharmaceutical Technology, and Bridge to
Life. These firms lead in developing advanced preservation solutions and
perfusion technologies. The report includes a detailed competition dashboard,
benchmarking, and market share analysis, highlighting strategies such as
product innovation, strategic collaborations, and expansion into emerging
markets. As the market evolves, these players are well-positioned to capitalize
on opportunities in advanced preservation techniques and global transplant
demand.
Strategic Recommendations and Future Implications
FactMR’s report offers actionable recommendations, urging
stakeholders to invest in NMP and AI-driven organ assessment technologies to
improve transplant outcomes. Providers should focus on cost-effective solutions
and expand cryogenic infrastructure in emerging markets like Asia-Pacific. The
study includes value chain analysis, PESTLE factors, and SWOT assessments to
support strategic decision-making. As organ transplant demand rises and
technologies advance, organ preservation solutions will remain pivotal in
saving lives and addressing the global organ shortage.
FactMR delivers comprehensive market reports and valuable
business insights, uncovering trends, growth paths, and competitive landscapes.
Committed to accuracy and reliability, FactMR empowers businesses with critical
data and strategic recommendations, enhancing market positioning. With a global
presence and experienced analysts, FactMR ensures reliable market intelligence,
equipping clients to capitalize on opportunities.
For more information, visit https://www.factmr.com/report/organ-preservation-solutions-market
Comments
Post a Comment